AIMC Topic: Drug Repositioning

Clear Filters Showing 251 to 260 of 270 articles

Deep Learning in the Quest for Compound Nomination for Fighting COVID-19.

Current medicinal chemistry
The current COVID-19 pandemic initiated an unprecedented response from clinicians and the scientific community in all relevant biomedical fields. It created an incredible multidimensional data-rich framework in which deep learning proved instrumental...

Deep learning of pharmacogenomics resources: moving towards precision oncology.

Briefings in bioinformatics
The recent accumulation of cancer genomic data provides an opportunity to understand how a tumor's genomic characteristics can affect its responses to drugs. This field, called pharmacogenomics, is a key area in the development of precision oncology....

Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.

European review for medical and pharmacological sciences
Researchers have found many similarities between the 2003 severe acute respiratory syndrome (SARS) virus and SARS-CoV-19 through existing data that reveal the SARS's cause. Artificial intelligence (AI) learning models can be created to predict drug s...

Revealing new therapeutic opportunities through drug target prediction: a class imbalance-tolerant machine learning approach.

Bioinformatics (Oxford, England)
MOTIVATION: In silico drug target prediction provides valuable information for drug repurposing, understanding of side effects as well as expansion of the druggable genome. In particular, discovery of actionable drug targets is critical to developing...

deepDR: a network-based deep learning approach to in silico drug repositioning.

Bioinformatics (Oxford, England)
MOTIVATION: Traditional drug discovery and development are often time-consuming and high risk. Repurposing/repositioning of approved drugs offers a relatively low-cost and high-efficiency approach toward rapid development of efficacious treatments. T...

[Artificial Intelligence-based Drug Discovery and Drug Repositioning].

Brain and nerve = Shinkei kenkyu no shinpo
The methodologies of computational drug discovery and drug repositioning (DR) based on biomolecular profile information are reviewed systematically. For big data drug discovery and DR, 1) methods of comparing gene expression profiles of the diseased ...

Drug knowledge bases and their applications in biomedical informatics research.

Briefings in bioinformatics
Recent advances in biomedical research have generated a large volume of drug-related data. To effectively handle this flood of data, many initiatives have been taken to help researchers make good use of them. As the results of these initiatives, many...

GOF/LOF knowledge inference with tensor decomposition in support of high order link discovery for gene, mutation and disease.

Mathematical biosciences and engineering : MBE
For discovery of new usage of drugs, the function type of their target genes plays an important role, and the hypothesis of "Antagonist-GOF" and "Agonist-LOF" has laid a solid foundation for supporting drug repurposing. In this research, an active ge...

Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.

Methods in molecular biology (Clifton, N.J.)
The drug discovery process is conventionally regarded as resource intensive and complex. Therefore, research effort has been put into a process called drug repositioning with the use of computational methods. Similarity-based methods are common in pr...